Replies to post #147571 on Biotech Values

[porkchop11]

but because bavi can be armed, it would constitute a new patent for future versions; kind of like the bavi imaging, no? I'm talking straight buy-out. Wouldn't that be considered by a potential buyer?

How about Neudexta? I'm thinking of getting back in eventually (30 day wash rule up soon).

all imo.

porkchop11